Medical Publications – Dr. James N. Keating
The following is a list of medical/scientific literature, written, published or contributed to by Dr. Keating.
Keating JN, Weir DG, Scott JM.
Factors affecting folate polyglutamate biosynthesis in the rat liver. In: Chemistry and Biology of Pteridines, Ed: JA Blair, 1983, 977-81. Walter de Gruyter, Berlin.
Keating JN, Weir DG, Scott JM.
The effect of ethanol consumption on folate polyglutamate biosynthesis in the rat. Biochem Pharmacol. 1985;34:1913-6
Keating JN, Weir DG, Scott JM.
Demonstration of methionine synthetase in intestinal mucosal cells of the rat. Clin Sci (Lond). 1985;69:287-92.
Keating JN, Choe H, Stokstad EL.
The effects of thyroxine status on hepatitic levels of 10-formyltetrahydrofolic acid: NADP oxidoreductase. In: Chemistry and Biology of Pteridines, Eds: BA Cooper and VM Whitehead.1986:950-8
Keating JN, Wada L, Stokstad EL, King JC.
Folic acid: effect of zinc absorption in humans and in the rat. Am J Clin Nutr. 1987;46:835-9.
Stokstad EL, Reisenauer A, Kusano G, Keating JN.
Effect of high levels of dietary folic acid on folate metabolism in vitamin B12 deficiency. Arch Biochem Biophys. 1988;265:407-14.
Keating JN, Kusano G, Stokstad EL.
Effect of thiouracil in modifying folate function in severe vitamin B12 deficiency. Arch Biochem Biophys 1988; 267:119-24.
Stokstad EL, Choe H, Nair CPP, Keating JN, Kusano G, Chan MMS.
The role of thyroxine in the regulation of folic acid metabolism. Biol Chem 1989;370:395-42.
Weir DG, Molloy AM, Keating S, McPartlin J, Kennedy S, Blanchflower J, Rice D, Scott JM.
Methylation deficiency causes vitamin B12 associated neuropathy in the pig. J Neurochem. 1988;51:1949-52.
Weir DG, Molloy AM, Keating S, McPartlin J, Kennedy S, Blanchflower J, Rice D, Scott JM.
Hypomethylation produces vitamin B12 associate neuropathy in the pig. In: Biomedicine and Physiology of vitamin B12. Proceedings of cobalamin 1988. The Children’s Medical Charity, London, 129-151.
Molloy AM, Keating S, Scott JM, Weir DG, Kennedy G, Kennedy S, Rice D.
Biochemical changes in porcine neural tissue after inactivation of methionine synthase with nitrous oxide. In: Chemistry and Biology of Pteridines. Eds. H-Ch Curtis, S Gisla, N Blau. 1990; Walter de Gruyter, Berlin. 881-884.
Sheehan BJ, Caffrey JF, Gunn HM, Keating JN.
Structural and biochemical changes in spinal myelopathy in twelve English foxhounds and two harriers. Vet Pathol. 1991;28:117-24.
Keating JN, Trimble KC, Mulcahy F, Scott JM, Weir DG.
Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet. 1991;337:935-9.
Weir DG, Molloy AM, Keating JN, Young PB, Kennedy S, Kennedy DG, Scott JM.
Correlation of the ration of S-adenosyl-L-methionine to S-adenosyl-L-homocystine in the brain and cerebrospinal fluid of the pig: implications for the determination of this methylation ratio in human brain. Clin Sci (Lond). 1992;82:93-7.
Dowling S, Kane D, Chua A, Keating S, Flood P, Keeling PW, Mulcahy FM.
An evaluation of percutaneous endoscopic gastrostomy feeding in AIDS. Int J STD AIDS. 1996;7:106-9.
Balluz IM, Farrell MA, Kay E, Staunton MJ, Keating JN, Shiels O, Cosby SL, Mabruk MJ, Sheahan BJ, Atkins GJ.
Colocalisation of human immunodeficiency virus and human cytomegalovirus in brain autopsy tissue from AIDS patients. Ir J Med Sci. 1996;165:133-8.
Landers D, Bergin C, O’Leary A, Merry C, Keating S, Mulcahy F. Dapsone induced methaemoglobinaemia. Int J STD AIDS. 1996;7:445-7.
Kane D, Murphy JM, Keating S, Wilson GF, Mulcahy F.
Renal ultrasound findings in sulphadiazine-induced renal failure. Br J Radiol. 1996;69:925-8.
Kane D, Keating S, McCann S, Mulcahy F.
The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: A case report and review. Int J STD AIDS. 1978:272-4.
Browne R, Sloan D, Fahy S, Keating S, Moran C, O’Connor J.
Detection of benzodiazepine abuse in opiate addicts. Ir Med J. 1998;91:18-19.
Browne R, Keating S, O’Connor J.
Sexual abuse in childhood and subsequent illicit drug abuse in adolescence and early adulthood. Ir J Psych Med. 1998;15:123-126.
Fahy S, Browne R, Sloan D, Keating S, O’Connor J.
An audit of violent incidents in a drug treatment centre. Ir J Psych Med 2000;17:29-33.
Barry J, Bourke M, Buckley M, Coughlan B, Crowley D, Cullen W, Dooley S, Keating S et al.
Hepatitis C among drug users: consensus guidelines on management in general practice. Ir J Med Sci, 2004;173:1-5.
Hopkins S, Coleman C, Kelliher M, Keating S et al.
Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin. Ir med J, 2005;193:1260-5
Keating S, O’Connor J, Sweeney B, Keenan E.
Apparent hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area. Ir J Med Sci, 2005;174:37-41
Roe B, Coughlan S, Dean J, Lambert JS, Keating S, Norris S, Bergin C, Hall WW.
Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients. Viral Immunol. 2009;22(1):39-48.
Swan D, Long J, Carr O, Flanagan J, Irish H, Keating S et al.
Barriers to and facilitators of Hepatitis C testing, management and treatment among current and former injecting drug users: a qualitative exploration. AIDS PATIENT CARE and STDs, 2010;24:753-62.
Review Articles
S Keating and C O’Morain.
Helicobacter pylori and gastroduodenal pathology. Irish Medical Journal. 1994;87:96-97.
S Keating.
Treating the complications of AIDS and HIV infection. Irish Medical News, 1995 (November 15th).
S Keating, D Kane, F Mulcahy.
Preventing AIDS. Journal of the Irish College of Physicians and Surgeons, 1996.
Keating S, Browne R, O’Connor J.
Hepatitis C infection in the drug using community. Irish Medical Times 1998 (September).
Booklet publications
S Keating 1999
Hepatitis C: A guide for drug users and their families
Published by the Eastern Region Health Authority.
S Keating 2001
Vaccination guidelines for patients attending the ERHA drug treatment clinics: A guide for doctors and nurses working in the HIV and addiction services
Published by the Eastern Region Health Authority.
S Keating 2003
Hepatitis C: A guide for drug users and their families
Published by the Drug Treatment Centre Board
Presentations and Abstract Publications
Keating JN, Weir DG, Scott JM.
Factors affecting folate polyglutamate biosynthesis in rat liver. Seventh international symposium of pteridine and folic acid derivatives: Chemical, biological and clinical aspects. University of St. Andrews, Scotland. 1982.
Keating JN, Weir DG, Scott JM.
Characteristics of methionine synthetase in rat small intestinal mucosal cells. Annual symposium of the Royal Academy of Medicine in Ireland. University College Cork, Ireland. 1984.
Keating JN, Weir DG, Scott JM.
Characteristics of methionine synthetase in rat small intestinal mucosal cells. FASEB, Anaheim, California, U.S. 1985.
Keating S, Morrison C, Buckley M, O’Morain C.
The use of cyclosporin in the management of acute exacerbations of inflammatory bowel disease. Irish Society of Hastroenterology, Winter Meeting, St. James’ Hospital, Dublin, Ireland. 1994.
Keating S, Morrison C, Buckley M, O’Morain C.
Helicobacter pylori eradication: A comparison of two regimes using omeprazole and amoxycillin. Irish Society of Gastroenterology, Winter Meeting, St. James’ Hospital, Dublin, Ireland. 1994.
Buckley M, Breslin N, McEneaney P, Keating S, Beattie S, Hamilton H, O’Morain C.
A short duration, inexpensive regime to eradicate helicobacter pylori. Irish Society of Gastroenterology, Winter Meeting, St. James’ Hospital, Dublin, Ireland. 1994.
Booth D, Keating S, Buckley M, Crowe J, Kelliher D, Weir DG, O’Morain C.
Does maintenance therapy with 5-aminosalicylic acid compounds sulphasalazine, olasalazine or mesalizine in patients with inflammaroy bowel disease cause renal disease? Irish Society of Gastroenterology, Winter Meeting, St. James’ Hospital, Dublin, Ireland. 1994.
Buckley M, Keating S, Xia H, Beattie S, Hamilton H, O’Morain C.
Omeprazole plus one or two antibiotics to eradicate H.pylori. Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterology Association, San Diego, California, 1995.
Keating S, Morrison C, Buckley M, O’Morain C.
The use of cyclosporin in the management of acute exacerbations of inflammatory bowel disease. Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterology Association, San Diego, California, 1995.
Booth D, Keating S, Buckley M, Crowe J, Kelliher D, Weir DG, O’Morain C.
Does maintenance therapy with 5-aminosalicylic acid compounds sulphasalazine, olasalazine or mesalizine in patients with inflammatory bowel disease cause renal disease? Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterology Association, San Diego, California, 1995.
Keating S, O’Leary A, Bergin C, Kane D, Mulcahy F.
Malignant neuroleptic syndrome. 4 cases in an Irish AIDS population. Second International Congress on Drug Therapy in HIV Infection, Glasgow, 1994. AIDS 1994.8:18
Keating S, O’Leary A, Bergin C, Kane D, Mulcahy F.
Adverse drug reactions in HIV positive patients: an Irish perspective. Second International Congress on Drug Therapy in HIV Infection. Glasgow, 1994. AIDS 1994.8:18.
Bergin C, Wallis F, O’Leary A, Keating S, Mulcahy F.
Experience with day case insertion of long term indwelling right atrial catherers in patients with AIDS. National Scientific Medical Meeting, (RCPI) 1995.
Kane D, Keating S, Mulcahy F.
Increased prevalence of biological false positive reactions to syphilis in an Irish HIV positive population. Spring Meeting of the Medical Society for the Study of Venereal Disease, Vienna, May 1995.
Dowling S, Kane D, Chua A, Keating S, Flood P, Keeling PWN, Mulcahy FM.
Percutaneous endoscopic gastrostomy feeding in advanced HIV infection. 1st International Meeting, Nutrition-HIV Infection, Cannes, April 1995.
Lyons F, Keating S, McKenna P, Mulcahy F.
Cervical neoplasia in HIV infection–case report. The Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. Copenhagen, September 1995.
Keating S, Kane D, Lyons F, Sothinathan R, Mulcahy FM.
Patient knowledge of sexually transmitted diseases in a genitourinary medicine clinic. The Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. Copenhagen, September 1995.
Keating S, McGonagle D, Bergin C, Kane D, O’Leary A, Mulcahy FM.
A low incidence of cytomegalovirus retinitis in a predominantly intravenous drug using AIDS population. The Fifth European conference on Clinical Aspects and Treatment of HIV infection, Copenhagen, September 1995.
Keating S, Bergin C, Merry C, Mulcahy F.
Cytomegalovirus infection: seroprevalence and incidence of disease in a predominatly intravenous drug using AIDS population. HIV in Clinical Practice, York, U.K., April 1996.
Bergin C, Clarke S, Merry C, O’Leary A, Keating S, Mulcahy F.
Gancyclovir-resistant herpes simplex infections in patients with AIDS. HIV in Clinical Practice, York, U.K., April 1996.
Keating S, Keeling PWN, Mulcahy F.
The seroprevalence of helicobacter pylori and the benefit of upper gastrointestinal endoscopy in a predominatly drug-using HIV positive population. 3rd Annual Meeting of the British HIV Association (BHIVA), Warwick University, U.K., April 1997.
Keating S, O’Connor J, Keenan E.
Apparent hepatitis viral clearance in an intravenous drug using cohort in the Dublin area. International Hepatitis C Conference, Trinity College, Dublin. 2003.
Keating S, O’Shea J, Bergin C, Bolger A, Keenan E.
On-site hepatitis C treatment in a drug treatment center in Dublin. 1st International Hepatitis C Meeting, Dublin Castle, June 2006.
Keating S.
Men’s issues – the challenges faced by men dealing with hepatitis C, Workshop Consultative Council on Hepatitis C Information Day, Croke Park Conference Centre, February 2008.